Cargando…
Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives
Neutralizing monoclonal antibody treatments for non-hospitalized patients with COVID-19 have been available since November 2020. However, they have been underutilized and access has been inequitable. To understand, from the clinician perspective, the factors facilitating or hindering monoclonal anti...
Autores principales: | Hamer, Mika K., Alasmar, Ahmed, Kwan, Bethany M., Wynia, Matthew K., Ginde, Adit A., DeCamp, Matthew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771255/ https://www.ncbi.nlm.nih.gov/pubmed/36550877 http://dx.doi.org/10.1097/MD.0000000000032191 |
Ejemplares similares
-
Clinician Perspectives on Monoclonal Antibody Treatment for High-Risk Outpatients with COVID-19: Implications for Implementation and Equitable Access
por: Kwan, Bethany M., et al.
Publicado: (2022) -
A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients
por: Fish, Lindsey E., et al.
Publicado: (2023) -
“All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19
por: Kwan, Bethany M., et al.
Publicado: (2022) -
Management of outpatient with totally implantable venous access Ports during the COVID-19 epidemic
por: Yan, Weipeng, et al.
Publicado: (2021) -
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
por: Wynia, Matthew K., et al.
Publicado: (2023)